Covid-19 Infection Management in Nursing Homes – Use of Oxygen and Dexamethasone (908)

Warning

exp date isn't null, but text field is

Abstract

Recent publications have suggested that dexamethasone reduces mortality in patients who are hospitalised with proven Covid-19 Infection and who require oxygen support.

Although these studies were performed only on hospitalised patients it should be noted that a large population recruited into the trial had significant morbidity and were in the same age category as nursing home residents. After reviewing these
publications it is assumed that some Nursing Home residents may therefore benefit from dexamethasone prescription. It should be noted that there was evidence of harm for patients with no oxygen requirement.

Resources

Use the button below to access this resource item.

Access this resource

Tags

All HSCPs

Last reviewed: 03 November 2021

Next review: 04 May 2022

Author(s): David Anderson

Version: 2

Author Email(s): [email protected]

Approved By: Covid-19 Tactical Group (HSCPs)

Document Id: 908